BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26588685)

  • 1. Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate.
    Oliveira TL; Grassmann AA; Schuch RA; Seixas Neto AC; Mendonça M; Hartwig DD; McBride AJ; Dellagostin OA
    PLoS One; 2015; 10(11):e0142821. PubMed ID: 26588685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.
    Forster KM; Hartwig DD; Oliveira TL; Bacelo KL; Schuch R; Amaral MG; Dellagostin OA
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):989-95. PubMed ID: 26676320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OmpL37 surface-exposed protein is expressed by pathogenic Leptospira during infection and binds skin and vascular elastin.
    Pinne M; Choy HA; Haake DA
    PLoS Negl Trop Dis; 2010 Sep; 4(9):e815. PubMed ID: 20844573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.
    Forster KM; Hartwig DD; Seixas FK; Bacelo KL; Amaral M; Hartleben CP; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):725-31. PubMed ID: 23486420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules.
    Oliveira TL; Bacelo KL; Schuch RA; Seixas FK; Collares T; Rodrigues OE; Vargas J; Nascimento RO; Dellagostin OA; Hartwig DD
    Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):712-716. PubMed ID: 27759768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis.
    Hartwig DD; Forster KM; Oliveira TL; Amaral M; McBride AJ; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):747-52. PubMed ID: 23515012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs.
    Lin X; Xiao G; Luo D; Kong L; Chen X; Sun D; Yan J
    BMC Microbiol; 2016 Oct; 16(1):241. PubMed ID: 27737644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the vaccine potentiality of 2 strains from Leptospira interrogans serogroup Ballum].
    Rodríguez AG; Jiménez YR; Santiesteban NB; Abreu YV; Osenes JF; González MG
    Rev Cubana Med Trop; 2005; 57(1):63-4. PubMed ID: 17966485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.
    Monaris D; Sbrogio-Almeida ME; Dib CC; Canhamero TA; Souza GO; Vasconcellos SA; Ferreira LC; Abreu PA
    Clin Vaccine Immunol; 2015 Aug; 22(8):965-73. PubMed ID: 26108285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF
    Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
    González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
    Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model.
    Lucas DS; Cullen PA; Lo M; Srikram A; Sermswan RW; Adler B
    Vaccine; 2011 Apr; 29(18):3413-8. PubMed ID: 21396409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of a commercial vaccine against Leptospira interrogans: Antibodies and cytokine levels.
    Fávero JF; Fritzen A; Lovato LT; Martins P; Baldissera MD; Stefani LM; Da Silva AS
    Microb Pathog; 2018 Jan; 114():46-49. PubMed ID: 29066380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection.
    Oliveira TL; Bacelo KL; Forster KM; Ilha V; Rodrigues OE; Hartwig DD
    Mem Inst Oswaldo Cruz; 2020; 115():e190396. PubMed ID: 32321154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters.
    Faisal SM; Yan W; Chen CS; Palaniappan RU; McDonough SP; Chang YF
    Vaccine; 2008 Jan; 26(2):277-87. PubMed ID: 18055070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.
    Yang HL; Zhu YZ; Qin JH; He P; Jiang XC; Zhao GP; Guo XK
    BMC Genomics; 2006 Nov; 7():293. PubMed ID: 17109759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit approach to evaluation of the immune protective potential of leptospiral antigens.
    Félix SR; Hartwig DD; Argondizzo AP; Silva ÉF; Seixas FK; Neto AC; Medeiros MA; Lilenbaum W; Dellagostin OA
    Clin Vaccine Immunol; 2011 Dec; 18(12):2026-30. PubMed ID: 22030369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Solubilization of components of outer membrane of Leptospira interrogans serovar mozdok by sodium desoxycholate and triton X-100 and evaluation of their immunogenic capacity and homologous and heterologous protection induced in hamsters].
    Rivera YF; Navarro YP; Mazorra YA; Rodríguez AG; Padrón Mde L; Valdés Y
    Rev Cubana Med Trop; 2005; 57(1):53-4. PubMed ID: 17966480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge.
    Maneewatch S; Tapchaisri P; Sakolvaree Y; Klaysing B; Tongtawe P; Chaisri U; Songserm T; Wongratanacheewin S; Srimanote P; Chongsa-nguanz M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):75-82. PubMed ID: 17891923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.
    Alt DP; Wilson-Welder J
    Biologicals; 2013 Sep; 41(5):323-4. PubMed ID: 23838569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.